The goal of evening out the out-of-pocket costs patients pay

... for provider-administered cancer therapies under the medical benefit versus self-administered cancer drugs under the pharmacy benefit is the goal of the Cancer Drug Coverage Parity Act introduced on June 11. Whether it will be adopted "is all politics of course. It doesn't cost the federal government any money so there is less resistance to the idea. Since it is viewed as being patient friendly — and against those money-hungry health plans — it reads well in the media and with voters. While you could say it is more government regulation, it technically isn't hurting anyone or adding bureaucracy, so even the right-wing conservatives may be open to it."

— Bill Sullivan, principal consultant at Specialty Pharmacy Solutions LLC, told AIS's Specialty Pharmacy News.